| Budget Amount *help |
¥18,330,000 (Direct Cost: ¥14,100,000、Indirect Cost: ¥4,230,000)
Fiscal Year 2011: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2010: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2009: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
|
|---|
| Research Abstract |
Transporter molecule that control renal handling of uric acid and effect of uricosuric-and anti-uricosuric drugs were analyzed using in vitro and in vivo model. OAT2 was newly found as the uric acid transporter in kidney. As the animal model, uric transporters expressed in rats were characterized and found to be useful as the model of uric acid disposition. In addition, as the extra-renal elimination pathways of uric acid, intestinal secretion was found to be very important and the BCRP transporter was found to be responsible for that process. Furthermore, for in vivo analysis in human, the method for the synthesis of PET probe of uric acid was succeeded. It was preliminarily applied in PET analysis in rats. All these studies related to the mechanism and evaluation method of uric acid disposition is useful for future development of drugs that can control serum uric acid level and physiological and pathological significance of uric acid.
|
